Literature DB >> 5099592

The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers.

J T Bigger, C C Jaffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5099592     DOI: 10.1016/0002-9149(71)90086-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

1.  Selective inhibition of K(+)-stimulation of Na,K-ATPase by bretylium.

Authors:  P E Tiku; P T Nowell
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 2.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

Authors:  M B Bacaner; J R Clay; A Shrier; R M Brochu
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 4.  Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Evaluation of drug-induced changes in myocardial repolarisation using the paced evoked response.

Authors:  R M Donaldson; A F Rickards
Journal:  Br Heart J       Date:  1982-10

6.  Pharmacological analysis of established ventricular fibrillation.

Authors:  E J Carlisle; J D Allen; W G Kernohan; W Leahey; A A Adgey
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

Review 7.  Class III antiarrhythmics in overdose. Presenting features and management principles.

Authors:  E W Leatham; D W Holt; W J McKenna
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

8.  Electrophysiological effects of melperone on isolated rabbit heart muscles.

Authors:  S Ikeguchi; S Hashimoto; M Horie; M Kadoya; T Konishi; C Kawai
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

9.  In vitro preparation of infarcted myocardium.

Authors:  B I Sasyniuk
Journal:  Environ Health Perspect       Date:  1978-10       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.